TLR9-B class agonist kit, Contains 100 ug of - ODN1668-1; ODN1826;and ODN2006 - ODN BW006 - B class, human/mouse - ODN 2007 - B-class, bovine/porcine - ODN D-SL01

Contact us
Catalog number: ODN-PK-5
Price: 768 €
Supplier: adi
Product name: TLR9-B class agonist kit, Contains 100 ug of - ODN1668-1; ODN1826;and ODN2006 - ODN BW006 - B class, human/mouse - ODN 2007 - B-class, bovine/porcine - ODN D-SL01
Quantity: 1 mg
Related search:

More details :

ELISA kit stock availability: Available In Stock
ELISA's description: Contains 100 ug of - ODN1668-1, ODN1826, bovine/porcine - ODN D-SL01, human/mouse - ODN 2007 - B-class, TLR9-B class agonist kit, and ODN2006 - ODN BW006 - B class
Category: Adjuvant/ODNs
S type: Adjuvant
Antibody's host is: see techfile
Purification: Affinity purified
Gene target: / - ODN 2007 - B-class, / - ODN D-SL01, Contains 100 of - ODN1668-1, ODN1826, ODN2006 - ODN BW006 - B class, TLR9-B class agonist kit
Short name: Contains 100 of - ODN1668-1, ODN1826, ODN2006 - ODN BW006 - B class, bovine/porcine - ODN D-SL01, human/mouse - ODN 2007 - B-class, TLR9-B class agonist kit
Host: mouse
Alternative name: Contains 100 ug on - ODN1668-1, H, ODN1826, bovine/swine - ODN D-SL01, sapiens/mouse - ODN 2007 - B-class, and ODN2006 - ODN BW006 - B class, toll-like receptor 9-B class agonist reagent
Alternative technique: kits
Alternative to gene target: Extracellular, TLR9 and IDBG-407857 and ENSG00000239732 and 54106, siRNA binding, this GO :0000139 and this GO lgi membrane and cellular component this GO :0002224 and toll-like receptor signaling pathway and biological process this GO :0002237 and response to molecule of bacterial origin and biological process this GO :0002755 and MyD88-dependent toll-like receptor signaling pathway and biological process this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005149 and interleukin-1 receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005764 and lysosome and cellular component this GO :0005768 and endosome and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005789 and endoplasmic reticulum membrane and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006954 and inflammatory response and biological process this GO :0007165 and signal transduction and biological process this GO :0007252 and I-kappaB phosphorylation and biological process this GO :0008286 and insulin receptor signaling pathway and biological process this GO :0010008 and endosome membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0016323 and basolateral plasma membrane and cellular component this GO :0016324 and apical plasma membrane and cellular component this GO :0030277 and maintenance of gastrointestinal epithelium and biological process this GO :0032009 and early pha this GO some and cellular component this GO :0032088 and negative regulation of NF-kappaB transcription factor activity and biological process this GO :0032715 and negative regulation of interleukin-6 production and biological process this GO :0032717 and negative regulation of interleukin-8 production and biological process this GO :0032722 and positive regulation of chemokine production and biological process this GO :0032728 and positive regulation of interferon-beta production and biological process this GO :0032733 and positive regulation of interleukin-10 production and biological process this GO :0032735 and positive regulation of interleukin-12 production and biological process this GO :0032741 and positive regulation of interleukin-18 production and biological process this GO :0032755 and positive regulation of interleukin-6 production and biological process this GO :0032757 and positive regulation of interleukin-8 production and biological process this GO :0032760 and positive regulation of tumor necrosis factor production and biological process this GO :0034122 and negative regulation of toll-like receptor signaling pathway and biological process this GO :0034123 and positive regulation of toll-like receptor signaling pathway and biological process this GO :0034162 and toll-like receptor 9 signaling pathway and biological process this GO :0035197 and siRNA binding and molecular function this GO :0036020 and endolysosome membrane and cellular component this GO :0042346 and positive regulation of NF-kappaB import into nucleus and biological process this GO :0042742 and defense response to bacterium and biological process this GO :0043123 and positive regulation of I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043507 and positive regulation of JUN kinase activity and biological process this GO :0045078 and positive regulation of interferon-gamma biosynthetic process and biological process this GO :0045087 and innate immune response and biological process this GO :0045356 and positive regulation of interferon-alpha biosynthetic process and biological process this GO :0045359 and positive regulation of interferon-beta biosynthetic process and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046330 and positive regulation of JNK cascade and biological process this GO :0050707 and regulation of cytokine secretion and biological process this GO :0050729 and positive regulation of inflammatory response and biological process this GO :0050829 and defense response to Gram-negative bacterium and biological process this GO :0051092 and positive regulation of NF-kappaB transcription factor activity and biological process this GO :0051770 and positive regulation of nitric-oxide synthase biosynthetic process and biological process, this GO :0004888 : transmembrane signaling receptor activity, this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005149 : interleukin-1 receptor binding and also this GO :0005515 : protein binding and also this GO :0035197 : siRNA binding, this GO :0005149 : interleukin-1 receptor binding, this GO :0005515 : protein binding, this GO :0035197 : siRNA binding, toll-like receptor 9

Related Products :

ODN-PK-5 TLR9-B class agonist kit, Contains 100 ug of - ODN1668-1; ODN1826;and ODN2006 - ODN BW006 - B class, human/mouse - ODN 2007 - B-class, bovine/porcine - ODN D-SL01 1 pk 550 € adi human
ODN-PK-2 Human TLR9-agonist kit; contains 100 ug of ODN2006-1; ODN2216-1; ODN2395-1; and negative controls ODN2006-1NC; ODN2216-1NC; ODN2395-1NC 1 pk 550 € adi human
ODN-PK-4 TLR9-A&C class agonist kit, Contains 100 ug of ODN1585-1; ODN2216-1; ODN2336-1;ODN 2395 and ODN M362; ODNDSL03 1 pk 550 € adi human
ODN2007-1NC ODN 2007- Type B bovine/porcine TLR9 Agonist (Negative Control), antigen grade 1 mg 695 € adi human
ODN2007-5NC ODN 2007- Type B bovine/porcine TLR9 Agonist (Negative Control), antigen grade 5 mg 1928 € adi human
ODN-PK-1 Mouse TLR9-agonist kit; contains 100 ug of ODN1585-1; ODN1826-1, ODN2395-1, and negative controls ODN1585-1NC; ODN1826-1-1NC, ODN2395-1NC 1 pk 550 € adi mouse
ODNINH47-1 ODN INH-47-Class R (restricted) inhibitory ODN TLR9 Antagonist-Palindromic variant of ODN INH-1-antigen grade 200 μg 260 € adi human
ATODN1-1 AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen grade 100 μg 333 € adi human
ATODN2-1 AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen grade 100 μg 333 € adi human
ATODN3-1 AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen grade 100 μg 333 € adi human
ODN2007-200 ODN 2007-Type B bovine/porcineTLR9 agonist-antigen grade, 200 ug 200 μg Ask price € adi human
ODN2007-1 ODN 2007-Type B bovine/porcineTLR9 agonist-antigen grade 1 mg 768 € adi human
ODN2007-5 ODN 2007-Type B bovine/porcineTLR9 agonist-antigen grade 5 mg 2363 € adi human
ODNINH18-1 ODN INH-18 class R (‘restricted’) inhibitory ODN-TLR9 antagonist antigen grade 200 µg 260 € adi human
ODN2006-1 ODN 2006 -Type B-human TLR9 agonist-antigen grade 1 mg 768 € adi human
ODN2006-5 ODN 2006 -Type B-human TLR9 agonist-antigen grade 5 mg 2363 € adi human
ODN2006-B ODN 2006 -Type B-human TLR9 agonist Biotin conjugate-antigen grade 50 μg 260 € adi human
ODN2006-F ODN 2006 -Type B-human TLR9 agonist FITC conjugate-antigen grade Custom Service Ask price € adi human
ODN2006-1NC ODN 2006- Type B human TLR9 Agonist (Negative Control), antigen grade 1 mg 695 € adi human
ODN2006-5NC ODN 2006- Type B human TLR9 Agonist (Negative Control), antigen grade 5 mg 1928 € adi human
ODN2216-200 ODN 2216-Type A human TLR9 Agonist.-antigen grade, 200ug 200 μg Ask price € adi human
ODN2216-1 ODN 2216-Type A human TLR9 Agonist.-antigen grade 1 mg 768 € adi human
ODN2216-5 ODN 2216-Type A human TLR9 Agonist.-antigen grade 5 mg 2363 € adi human
ODN2216-B ODN 2216-Type A human TLR9 Agonist Biotin conjugate-antigen grade Custom Service Ask price € adi human
ODN2216-F ODN 2216-Type A human TLR9 Agonist FITC conjugate-antigen grade Custom Service Ask price € adi human
ODN2216-1NC ODN 2216- Type A human TLR9 Agonist (Negative Control), antigen grade 1 mg 695 € adi human
ODN2216-5NC ODN 2216- Type A human TLR9 Agonist (Negative Control), antigen grade 5 mg 1928 € adi human
ODN2336-1NC ODN 2336- Type A human specific TLR9 Agonist (Negative Control), antigen grade 1 mg 695 € adi human
ODN2336-5NC ODN 2336- Type A human specific TLR9 Agonist (Negative Control), antigen grade 5 mg 1928 € adi human
ODN2395-1 ODN 2395-Type C human/murine TLR9 agonist-antigen grade 1 mg 768 € adi human